CLARITAS RX ASCEND Trademark

Trademark Overview


On Wednesday, August 9, 2023, a trademark application was filed for CLARITAS RX ASCEND with the United States Patent and Trademark Office. The USPTO has given the CLARITAS RX ASCEND trademark a serial number of 98125034. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 19, 2024. This trademark is owned by CLARITAS RX INC.. The CLARITAS RX ASCEND trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services featuring software to aggregate and process data, generate and share information and reports in the field of pharmaceuticals, and provide advanced predictive analytics to support patient accessibility to pharmaceuticals, pharmaceutical contracting, patient services insights, and medication payer insights, and commercial operations for pharmaceutical companies for use in developing strategies for commercialization of products and services within the field of biopharmaceuticals

General Information


Serial Number98125034
Word MarkCLARITAS RX ASCEND
Filing DateWednesday, August 9, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, November 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2024

Trademark Statements


Section 2(f) Limitation Statementas to "RX" has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement.
NOT AVAILABLE"RX"
Goods and ServicesSoftware as a service (SAAS) services featuring software to aggregate and process data, generate and share information and reports in the field of pharmaceuticals, and provide advanced predictive analytics to support patient accessibility to pharmaceuticals, pharmaceutical contracting, patient services insights, and medication payer insights, and commercial operations for pharmaceutical companies for use in developing strategies for commercialization of products and services within the field of biopharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 10, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCLARITAS RX INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameCLARITAS RX INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Saturday, August 12, 2023NEW APPLICATION ENTERED
Sunday, September 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 9, 2024ASSIGNED TO EXAMINER
Wednesday, April 10, 2024NON-FINAL ACTION WRITTEN
Wednesday, April 10, 2024NON-FINAL ACTION E-MAILED
Wednesday, April 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 29, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, August 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 29, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, August 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 15, 2024NON-FINAL ACTION WRITTEN
Monday, July 15, 2024NON-FINAL ACTION E-MAILED
Thursday, August 29, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, September 18, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 8, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 8, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, December 9, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, November 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT